Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-11-30
2009-10-27
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S184100, C424S185100, C424S190100, C424S234100, C424S278100, C530S300000, C530S350000
Reexamination Certificate
active
07608277
ABSTRACT:
The present invention provides transcriptionally active Mtb polynucleotides, recombinant Mtb peptides and polypeptides, and immunogenic Mtb antigens. Immunogenic compositions are also provided that may be useful as recombinant, subunit and DNA vaccines. In addition, the invention provides diagnostic kits for Mtb.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 6280977 (2001-08-01), Liang et al.
patent: 6350456 (2002-02-01), Reed et al.
patent: 6403100 (2002-06-01), Barry et al.
patent: 6458366 (2002-10-01), Reed et al.
patent: 6544522 (2003-04-01), Skeiky et al.
patent: 6592877 (2003-07-01), Reed et al.
patent: 6641814 (2003-11-01), Andersen et al.
patent: 6936470 (2005-08-01), Liang et al.
patent: WO88/05823 (1988-08-01), None
patent: WO 98/30699 (1998-06-01), None
patent: WO 99/02670 (1999-01-01), None
patent: WO 99/09186 (1999-02-01), None
patent: WO00/21983 (2000-04-01), None
patent: WO 00/21983 (2000-04-01), None
patent: WO 02/04018 (2002-01-01), None
patent: WO 02/083871 (2002-10-01), None
patent: WO03/033530 (2003-04-01), None
patent: WO 2006/060484 (2006-06-01), None
GenBank search result, AAP80214.
Hochuli, E., et al. “Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent”, Bio/Technology, vol. 6, No. 11, pp. 1321-1325, 1988.
Bird, et al. “Single-Chain Antigen-Binding Proteins.” Science 242:423-26 (1988).
Chow et al. “Improvement of Hepatitis B Virus DNA Vaccines by Plasmids Coexpressing Hepatitis B Surface Antigen and Interleukin-2.” J. Virol. 71(1):169-178 (1997).
Cole, et al. “The EBV-Hybridoma Technique and its Application to Human Lung Cancer.” Monoclonal Antibodies And Cancer Therapy. Alan R. Liss, Inc., New York. 77-96 (1985).
Cole, et al. “Generation of human monoclonal antibodies reactive with cellular antigens.” Proc. Natl. Acad. Sci. USA. 80:2026-30 (1983).
Delcher, et al. “Improved microbial gene identification with GLIMMER.” Nucleic Acids Res. 27(23):4636-4641 (1999).
Furth, et al. “Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.” Proc. Natl. Acad. Sci. USA. 91:9302-6 (1994)).
Heller et al. “Electroporation for targeted gene transfer.” Expert Opin. Drug Deliv. 2(2):255-268 (2005).
Huse, et al. “Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda.” Science. 246: 1275-81 (1989).
Huston, et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced inEscherichia coli. Proc. Natl. Acad. Sci. USA. 85:5879-83 (1988).
International Search Report for International Application No. PCT/US2005/043329 dated Oct. 10, 2006.
Köhler and Milstein. “Continuous cultures of fused cells secreting antibody of predefined specificity.” Nature. 256:495-7 (1975).
Kozbor, et al. “The production of monoclonal antibodies from human lymphocytes.” Immunology Today. 4(3):72-79 (1983).
Lee et al. “Optimal Induction of Hepatitis C Virus Envelope-Specific Immunity by Bicistronic Plasmid DNA Inoculation with the Granulocyte-Macrophage Colony-Stimulating Factor Gene.” J. Virol. 72(10):8430-8436 (1998).
Lee et al. “DNA inoculations with HIV-1 recombinant genomes that express cytokine genes enhance HIV-1 specific immune responses.” Vaccine. 17:473-479 (1999).
McClements et al. “Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.” Proc. Natl. Acad. Sci. USA. 93:11414-11420 (1996).
Morrison, et al. “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains.” Proc. Natl. Acad. Sci. 81:6851-6855 (1984).
No, et al. “Ecdysone-inducible gene expression in mammalian cells and transgenic mice.” Proc. Natl. Acad. Sci. USA. 93:3346-51 (1996).
Salzberg et al. “Microbial gene identification using interpolated Markov models.” Nucleic Acids Res. 26(2): 544-548 (1998).
Takeda, et al. “Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences.” Nature. 314:452-54 (1985).
Ulmer at al. “Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein.” Science. 259:1745-1749 (1993).
Wang, et al. “Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation.” Virology. 211:102-112 (1995).
Ward, et al. “Binding activities of a repertoire of single immunoglobulin variable domains secreted fromEscherichia coli.” Nature. 341:544-46 (1989).
Xiang et al. “Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective Immunity against Rabies Virus.” Virology. 199:132-140 (1994).
He Huaping
Roth David
Gene Therapy Systems, Inc.
Knobbe Martens Olson & Bear LLP
Swartz Rodney P.
LandOfFree
Tuberculosis nucleic acids, polypeptides and immunogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tuberculosis nucleic acids, polypeptides and immunogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tuberculosis nucleic acids, polypeptides and immunogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082495